RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
-0.75%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.76B
AUM Growth
+$4.76B
(-5.8%)
Cap. Flow
+$78.2M
Cap. Flow
% of AUM
1.64%
Top 10 Holdings %
Top 10 Hldgs %
26.26%
Holding
166
New
11
Increased
69
Reduced
16
Closed
13
Top Buys
| 1 |
Baxter International
BAX
|
$36.2M |
| 2 |
Warby Parker
WRBY
|
$34.5M |
| 3 |
Ultragenyx Pharmaceutical
RARE
|
$30.3M |
| 4 |
Immuneering
IMRX
|
$28.9M |
| 5 |
Ascendis Pharma
ASND
|
$26.5M |
Top Sells
| 1 |
ONC
BeOne Medicines Ltd. American Depositary Shares
ONC
|
$68.6M |
| 2 |
Ardelyx
ARDX
|
$39.8M |
| 3 |
Biogen
BIIB
|
$39.3M |
| 4 |
Boston Scientific
BSX
|
$34.2M |
| 5 |
PPD
PPD, Inc. Common Stock
PPD
|
$31.1M |
Sector Composition
| 1 | Healthcare | 93.53% |
| 2 | Consumer Staples | 1.58% |
| 3 | Industrials | 0.82% |
| 4 | Financials | 0.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Mirum Pharmaceuticals
MIRM
$3.71B
| $30.4M | 0.64% | 1,525,623 +1,900 | +0.1% | +$37.8K |
|
|
CVET
52
DELISTED
Covetrus, Inc. Common Stock
CVET
| $29.5M | 0.62% | 1,623,500 +168,500 | +12% | +$3.06M |
|
|
53
Immuneering
IMRX
$245M
| $28.9M | 0.61% | +1,089,816 | New | +$28.9M |
|
|
SRRA
54
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $28.8M | 0.61% | 1,313,997 +295,339 | +29% | +$6.47M |
|
55
Mersana Therapeutics
MRSN
$36.5M
| $28.5M | 0.6% | 3,020,702 +175,084 | +6% | +$1.65M |
|
56
Dynavax Technologies
DVAX
$1.19B
| $27.5M | 0.58% | 1,429,921 -250,000 | -15% | -$4.8M |
|
57
Atea Pharmaceuticals
AVIR
$267M
| $26.3M | 0.55% | 750,307 -40,826 | -5% | -$1.43M |
|
58
iRhythm Technologies
IRTC
$5.46B
| $26.2M | 0.55% | 448,000 | – | – |
|
59
DexCom
DXCM
$29.5B
| $25.4M | 0.53% | 46,500 +900 | +2% | +$492K |
|
60
Pulmonx
LUNG
$69.7M
| $25.2M | 0.53% | 700,000 +107,500 | +18% | +$3.87M |
|
61
Guardant Health
GH
$8.41B
| $25M | 0.53% | 200,000 | – | – |
|
62
Lifestance Health
LFST
$2.13B
| $24.5M | 0.51% | 1,687,500 +187,500 | +13% | +$2.72M |
|
63
Cullinan Oncology
CGEM
$445M
| $24.3M | 0.51% | 1,075,912 | – | – |
|
64
Acumen Pharmaceuticals
ABOS
$82.4M
| $23.5M | 0.49% | +1,579,191 | New | +$23.5M |
|
|
ABCM
65
DELISTED
Abcam plc American Depositary Shares
ABCM
| $23.3M | 0.49% | 1,147,588 +50,088 | +5% | +$1.02M |
|
|
WHWK
66
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $22.5M | 0.47% | 764,701 +631,326 | +473% | +$18.5M |
|
|
AMRN
67
Amarin Corp
AMRN
$311M
| $22M | 0.46% | 4,320,000 | – | – |
|
|
ICVX
68
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $21.7M | 0.46% | +734,215 | New | +$21.7M |
|
69
CONMED
CNMD
$1.68B
| $21.3M | 0.45% | 162,500 | – | – |
|
70
Madrigal Pharmaceuticals
MDGL
$9.76B
| $20.9M | 0.44% | 262,500 | – | – |
|
71
Bolt Biotherapeutics
BOLT
$9.85M
| $20.9M | 0.44% | 1,649,248 +30,000 | +2% | +$380K |
|
72
NovoCure
NVCR
$1.38B
| $20.3M | 0.43% | 175,000 | – | – |
|
73
BioMarin Pharmaceuticals
BMRN
$11.2B
| $19.6M | 0.41% | 253,500 | – | – |
|
|
OSH
74
DELISTED
Oak Street Health, Inc.
OSH
| $18.8M | 0.39% | 441,000 +66,000 | +18% | +$2.81M |
|
|
EPZM
75
DELISTED
Epizyme, Inc
EPZM
| $18.4M | 0.39% | 3,593,885 +582,398 | +19% | +$2.98M |
|